Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

Brain metastases remain a critical issue in the management of non-small cell lung cancer (NSCLC) because of the high frequency and poor prognosis, with survival rates often measured in just months. The local treatment approach remains the current standard of care, but management of multiple asymptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Likui, Zhao, Wuchen, Ye, Bo, Chen, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130929/
https://www.ncbi.nlm.nih.gov/pubmed/34017689
http://dx.doi.org/10.3389/fonc.2021.670313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130929/
https://www.ncbi.nlm.nih.gov/pubmed/34017689
http://dx.doi.org/10.3389/fonc.2021.670313

Ejemplares similares